
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11225485
[patent_doc_number] => 09453200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Apparatus and methods for cell isolation'
[patent_app_type] => utility
[patent_app_number] => 14/121390
[patent_app_country] => US
[patent_app_date] => 2014-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 13578
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14121390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/121390 | Apparatus and methods for cell isolation | Aug 27, 2014 | Issued |
Array
(
[id] => 10499810
[patent_doc_number] => 09228206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Method for gene transfer'
[patent_app_type] => utility
[patent_app_number] => 14/457453
[patent_app_country] => US
[patent_app_date] => 2014-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14347
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14457453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/457453 | Method for gene transfer | Aug 11, 2014 | Issued |
Array
(
[id] => 11922917
[patent_doc_number] => 09790488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Mutated internal ribosomal entry site (IRES) for controlled gene expression'
[patent_app_type] => utility
[patent_app_number] => 14/909264
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17294
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909264
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909264 | Mutated internal ribosomal entry site (IRES) for controlled gene expression | Jul 31, 2014 | Issued |
Array
(
[id] => 10989326
[patent_doc_number] => 20160186270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'SIGNATURE OF CYCLING HYPOXIA AND USE THEREOF FOR THE PROGNOSIS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/908825
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 25805
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908825
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908825 | SIGNATURE OF CYCLING HYPOXIA AND USE THEREOF FOR THE PROGNOSIS OF CANCER | Jul 31, 2014 | Abandoned |
Array
(
[id] => 11548747
[patent_doc_number] => 09617580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-11
[patent_title] => 'Method for the quantitative assessment of global and specific DNA repair capacities of at least one biological medium, and the applications therefor'
[patent_app_type] => utility
[patent_app_number] => 14/336453
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7455
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336453
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336453 | Method for the quantitative assessment of global and specific DNA repair capacities of at least one biological medium, and the applications therefor | Jul 20, 2014 | Issued |
Array
(
[id] => 11555415
[patent_doc_number] => 20170101659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'METHODS FOR INCREASING MOLECULAR DIVERSITY OF POLYKETIDES AND NON-RIBOSOMAL PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/903190
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 67390
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903190 | Methods for increasing molecular diversity of polyketides and non-ribosomal proteins | Jul 8, 2014 | Issued |
Array
(
[id] => 11040544
[patent_doc_number] => 20160237493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'BIOMARKER IDENTIFICATION'
[patent_app_type] => utility
[patent_app_number] => 14/900122
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 128171
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900122
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/900122 | Biomarker identification | Jun 17, 2014 | Issued |
Array
(
[id] => 16956221
[patent_doc_number] => 11060065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Tissue structure and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 14/897161
[patent_app_country] => US
[patent_app_date] => 2014-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12161
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 317
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897161
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897161 | Tissue structure and preparation method thereof | Jun 8, 2014 | Issued |
Array
(
[id] => 11284803
[patent_doc_number] => 09500654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Methods for identifying protein-protein interactions'
[patent_app_type] => utility
[patent_app_number] => 14/297824
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 10666
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297824
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/297824 | Methods for identifying protein-protein interactions | Jun 5, 2014 | Issued |
Array
(
[id] => 10498552
[patent_doc_number] => 09226942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Expanding hematopoietic stem cells'
[patent_app_type] => utility
[patent_app_number] => 14/294664
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8318
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294664
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/294664 | Expanding hematopoietic stem cells | Jun 2, 2014 | Issued |
Array
(
[id] => 10615093
[patent_doc_number] => 09334527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Inhibitors of human EZH2, and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/290642
[patent_app_country] => US
[patent_app_date] => 2014-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 51668
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/290642 | Inhibitors of human EZH2, and methods of use thereof | May 28, 2014 | Issued |
Array
(
[id] => 10946255
[patent_doc_number] => 20140349276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'SIGNAL PROPAGATION BIOMOLECULES, DEVICES AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/283993
[patent_app_country] => US
[patent_app_date] => 2014-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 22523
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14283993
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/283993 | Signal propagation biomolecules, devices and methods | May 20, 2014 | Issued |
Array
(
[id] => 10939900
[patent_doc_number] => 20140342920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'Biomarkers for Non-Hodkin Lymphomas and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/282837
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26331
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282837
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/282837 | Biomarkers for non-hodgkin lymphomas and uses thereof | May 19, 2014 | Issued |
Array
(
[id] => 10057534
[patent_doc_number] => 09096880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Solubility enhancing peptide and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/275903
[patent_app_country] => US
[patent_app_date] => 2014-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3233
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275903
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275903 | Solubility enhancing peptide and use thereof | May 12, 2014 | Issued |
Array
(
[id] => 12009933
[patent_doc_number] => 09803241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Methods and compositions for determining a graft tolerant phenotype in a subject'
[patent_app_type] => utility
[patent_app_number] => 14/270206
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 13066
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/270206 | Methods and compositions for determining a graft tolerant phenotype in a subject | May 4, 2014 | Issued |
Array
(
[id] => 10844271
[patent_doc_number] => 08871445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'CRISPR-Cas component systems, methods and compositions for sequence manipulation'
[patent_app_type] => utility
[patent_app_number] => 14/259420
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 54976
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259420 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Apr 22, 2014 | Issued |
Array
(
[id] => 10684422
[patent_doc_number] => 20160030568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER'
[patent_app_type] => utility
[patent_app_number] => 14/258572
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18948
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258572
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258572 | COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER | Apr 21, 2014 | Abandoned |
Array
(
[id] => 9823331
[patent_doc_number] => 08932814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes'
[patent_app_type] => utility
[patent_app_number] => 14/258458
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 52557
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258458 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Apr 21, 2014 | Issued |
Array
(
[id] => 9656782
[patent_doc_number] => 20140227787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 14/256912
[patent_app_country] => US
[patent_app_date] => 2014-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 31049
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14256912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/256912 | CRISPR-Cas systems and methods for altering expression of gene products | Apr 17, 2014 | Issued |
Array
(
[id] => 10548375
[patent_doc_number] => 09272986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex'
[patent_app_type] => utility
[patent_app_number] => 14/254291
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38322
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/254291 | Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex | Apr 15, 2014 | Issued |